FAEFHI
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
FAEFHI, also known as 4-(2-aminoethyl)-5-hydroxyindole, is a serotonin receptor modulator of the indole group related to serotonin and other tryptamines. It is a positional isomer of serotonin in which the ethylamine side chain at the 3 position of the indole ring system has been moved to the 4 position. FAEFHI can also be thought of as a greatly simplified analogue of LSD and hence partial ergoline. Although FAEFHI shows significant affinity for serotonin receptors, it had much lower affinity than serotonin or tryptamine (171-fold lower than serotonin and 5-fold lower than tryptamine). In addition, it did not show serotonin-like activity (i.e., serotonin receptor agonism) even at very high concentrations in vitro. FAEFHI was first described in the scientific literature by 1984.
FAEFHI, also known as 4-(2-aminoethyl)-5-hydroxyindole, is a serotonin receptor modulator of the indole group related to serotonin and other tryptamines. It is a positional isomer of serotonin in which the ethylamine side chain at the 3 position of the indole ring system has been moved to the 4 position. FAEFHI can also be thought of as a greatly simplified analogue of LSD and hence partial ergoline. Although FAEFHI shows significant affinity for serotonin receptors, it had much lower affinity than serotonin or tryptamine (171-fold lower than serotonin and 5-fold lower than tryptamine). In addition, it did not show serotonin-like activity (i.e., serotonin receptor agonism) even at very high concentrations in vitro. FAEFHI was first described in the scientific literature by 1984.
See also
Partial ergoline Diaza-2C-DFLY FHATHBIN Ropinirole RU-27251 UCD0179 WXVL_BT0793LQ2118
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374611487 under CC BY-SA 4.0; modifications have been made.